Bladder Cancer Clinical Trials

Bladder Cancer studies recruiting patients for novel treatments. Filter by phase, distance, and inclusion criteria to find your perfect bladder cancer clinical trial.

Filter Clinical TrialsFilter Clinical Trials

LOCATION

Anywhere

FILTER TRIALS

This study will test a drug called enfortumab vedotin in participants with a type of bladder cancer called non-muscle invasive bladder cancer (NMIBC). This study will also evaluate what the side effects are and if the drug works to treat NMIBC. A side effect is anything a drug does to you…

This study is evaluating whether a drug called TAR-200 can help treat cancer.

This study is evaluating whether a drug may help improve survival in patients with bladder cancer.

This study is evaluating whether a combination of two drugs may help treat early stage bladder cancer.

This study is evaluating whether a combination of two drugs may help treat bladder cancer.

Magnetic Resonance Imaging

This study is evaluating whether a new MRI protocol may help determine the stage of bladder cancer.

This study is evaluating whether a combination of chemotherapy and immunotherapy may help treat bladder cancer.

This study is evaluating whether a drug called TAR-200 is safe and well tolerated.

This study is evaluating whether an experimental drug (enfortumab vedotin) can shrink cancer of the urinary system (urothelial cancer).

This study is evaluating whether cabozantinib is safe and effective for treating advanced urothelial cancer.

Pembrolizumab/Vibostolimab Co-Formulation

This study is evaluating whether a combination of a drug and a light therapy is better than a drug alone in treating cancer.

This clinical trial is evaluating a drug called BT8009 alone and in combination with nivolumab in participants with advanced solid tumors associated with Nectin-4 expression or in participants with advanced solid tumor malignancies having renal insufficiency. The main goals of this study …

This study is evaluating whether a drug may help treat bladder cancer.

This study is evaluating whether a drug may help prevent bladder cancer from returning.

This study is evaluating whether a combination of drugs may help treat bladder cancer.

This study is evaluating whether a drug called NKTR-214 can help treat cancer.

This study is evaluating whether a combination of medications may help treat bladder cancer.

This study is evaluating whether a drug called durvalumab can improve the survival of people with cancer.

Background: Non-muscle-invasive bladder cancer is in the early stages. But it usually comes back after treatment. The drugs Vicineum and Durvalumab may help the immune system find and destroy cancer cells. Objective: To test if the drugs Durvalumab and Vicineum together are safe and eff…

This study is evaluating whether pembrolizumab in combination with vorinostat is safe and effective in patients with advanced prostate, renal or urothelial cell carcinoma.

Erdafitinib Intravesical Delivery System

The purpose of the study in Part 1 (dose escalation) is to determine the recommended Phase 2 dose(s) (RP2D[s]) and in Part 2 (dose expansion) is to determine the safety of Erdafitinib Intravesical Delivery System administered at the RP2D(s).

This study is evaluating whether a new treatment for bladder cancer is safe and tolerable.

This study is evaluating whether a drug may help treat solid tumors.

Fiducial marker placement

This study is evaluating whether gold markers placed around a bladder tumor site may help identify the tumor location at the time of radiation treatment.

This trial will look at a drug called SGN-B6A to find out whether it is safe for people who have solid tumors. It will study SGN-B6A to find out what its side effects are. A side effect is anything the drug does besides treating cancer. It will also study whether SGN-B6A works to treat sol…

This study is evaluating whether a drug may help treat advanced or metastatic solid tumors.

This study is evaluating whether a drug may help treat cancer.

This study is evaluating whether a drug may help treat solid tumors.

enfortumab vedotin (EV)

This study is evaluating whether an experimental drug may help treat bladder cancer.

This study is evaluating whether a combination of two drugs may help treat bladder cancer.

This study is evaluating whether a decision aid can help patients with bladder cancer make better decisions about their care.

personalized ultrafractionated stereotactic ablative radiotherapy

This study is evaluating whether radiation therapy is effective in patients with bladder cancer who are receiving immunotherapy.

This is a clinical study with an orally administered drug, BDTX-189 in participants with advanced solid tumors that have select mutations or alterations in human epidermal growth factor receptor 2 (HER2/ErbB2) genes or epidermal growth factor receptor (EGFR/ErbB1). The main goals of this s…

Derazantinib various dose levels in combination with atezolizumab

This study is evaluating whether a drug may help treat advanced urothelial cancer.

This study is evaluating whether a combination of atezolizumab and guadecitabine is safe and tolerable.

This study is evaluating whether a new drug can be safely combined with standard chemotherapy drugs.

This study is evaluating whether a drug called ramucirumab can be used to treat people with bladder cancer.

This study is evaluating whether a combination of two drugs may help treat bladder cancer.

This study is evaluating whether whole brain radiation can lower the chances of developing brain tumors in patients with small cell carcinoma of the urinary tract, including the bladder.

This study is evaluating whether a drug may help treat bladder cancer.

CRIS - Cancer Resource Information Support

This study is evaluating whether a multi-stage intervention may help patients and caregivers prepare for bladder cancer surgery.

TLD-1433 Bladder infusion and Photodynamic Therapy

This study is evaluating whether a light treatment may help treat bladder cancer.

Bacillus Calmette-Guerin (BCG)

This study is evaluating whether a drug called Durvalumab can be used to treat bladder cancer.

Avelumab (MSB0010718C)

This study is evaluating whether a drug called avelumab can be used to treat lung cancer and urothelial cancer.

This study is evaluating whether a drug called atezolizumab can help treat patients with non-muscle invasive bladder cancer that has come back and has not responded to treatment with Bacillus Calmette-Guerin (BCG).

This is a Phase Ib/II, open-label, multi-center and competitive enrollment study of ALT-801 combined with gemcitabine for patients who have BCG failure (defined as refractory, relapsing or intolerant), non-muscle invasive bladder cancer and refuse or are not medically fit to undergo a radi…

This study is evaluating whether chemotherapy and radiation therapy work better than radiation therapy alone.

This study will test whether enfortumab vedotin combined with pembrolizumab is an effective treatment for people with bladder cancer (urothelial carcinoma) involving the lymph nodes who are going to have surgery to remove their cancer (cystectomy). The researchers will look at whether trea…

Enfortumab vedotin (EV)

This study is evaluating whether a combination of two drugs may help treat people with a certain type of bladder cancer.

Bacillus Calmette-Guerin

The purpose of this study is to learn about the safety and effects of the study medicine (sasanlimab) in people with non-muscle invasive bladder cancer. This study is seeking participants whose bladder cancer is still in early stages, has not spread outside of the bladder, has been removed…

This study is evaluating whether a PET scan can help determine the extent of muscle invasive bladder cancer.

This study is evaluating whether a virus which is weakened and cannot cause measles may help treat bladder cancer.

This study is evaluating whether a drug may help prevent cancer from returning in individuals who have already undergone treatment.

This study is evaluating whether a common pain reliever may help treat cancer.

This study is evaluating whether a risk-adapted approach to the treatment of muscle invasive bladder cancer is safe and effective.

This is a multi-institutional, randomized, placebo controlled, double-blinded phase II trial of maintenance pembrolizumab versus placebo after first-line chemotherapy in patients with metastatic urothelial cancer who have achieved at least stable disease on first-line chemotherapy.

This study is evaluating whether a new drug can prevent recurrence of bladder cancer.

This study is evaluating whether a drug called trilaciclib can be used to treat bladder cancer.

High-Intensity Interval Training

This study is evaluating whether exercise can improve bladder cancer patients' quality of life.

This study is evaluating whether acupuncture may help reduce side effects of intravesical BCG for patients with bladder cancer.

Radical cystectomy (RC)

This study is evaluating whether a combination of two drugs may help treat bladder cancer.

This study is evaluating whether an immunotherapy drug may help treat bladder cancer.

This study is evaluating whether a new drug called M7824 can help people with advanced or metastatic biliary tract cancer.

This study is evaluating whether a drug called nivolumab can be used to treat bladder cancer.

This study is evaluating whether a drug may help treat advanced or metastatic urothelial cancer.

This study is evaluating whether atezolizumab can improve survival in people with bladder cancer.

therapeutic extended lymphadenectomy

This study is evaluating whether extended pelvic lymphadenectomy is more effective than standard pelvic lymphadenectomy in treating patients with invasive bladder cancer.

This is a single arm, Phase II trial involving the use of atezolizumab plus platinum and etoposide for patients with locally advanced urothelial cancer. The primary goal of this trial is to assess the pathologic complete response rate at cystectomy in patients after being treated with a co…

This study is evaluating whether a combination of drugs may be more effective than BCG for treating bladder cancer.

This study is evaluating whether a combination of two drugs may help treat muscle invasive bladder cancer.

This study is evaluating whether a combination of drugs may help treat bladder cancer.

This study is evaluating whether a combination of a drug and a chemical may help treat bladder cancer.

This study is evaluating whether daratumumab is safe and tolerable in patients with metastatic renal cell carcinoma and patients with muscle invasive bladder cancer.

This study is evaluating whether atezolizumab with cobimetinib works better than atezolizumab alone in treating patients with bile duct cancer that has spread to other places in the body (metastatic) and cannot

Intravenous MK-3475/ Intravesical BCG

This study is evaluating whether a drug called MK-3475 can be safely given with BCG to treat bladder cancer.

This study is evaluating whether a chemical found in soy beans may help with lower urinary tract symptoms in patients with bladder cancer.

This study is evaluating whether radiation therapy given together with chemotherapy works better than radiation therapy alone in treating patients with stage I bladder cancer.

This study is being conducted to evaluate the safety and determine the recommended Phase 2 dose (RP2D) of UGN-301 (zalifrelimab) administered intravesically as monotherapy and in combination with other agents in patients with recurrent NMIBC.

This study is evaluating whether a drug called erdafitinib can be used to treat bladder cancer.

This study is evaluating whether a combination of two treatments may help treat bladder cancer.

This study is evaluating whether a combination of two treatments may be effective for individuals with recurrent bladder cancer.

This study is evaluating whether a combination of a drug and a vaccine may be more effective than the vaccine alone in treating bladder cancer.

External Beam Radiation Therapy